Breaking: Is Biostar Pharmaceuticals Inc a Buy? The Stock Rises Again

Breaking: Is Biostar Pharmaceuticals Inc a Buy? The Stock Rises Again

The stock of Biostar Pharmaceuticals Inc (NASDAQ:BSPM) is a huge mover today! About 2.49M shares traded hands or 141.75% up from the average. Biostar Pharmaceuticals Inc (NASDAQ:BSPM) has risen 46.58% since March 8, 2016 and is uptrending. It has outperformed by 37.26% the S&P500.
The move comes after 8 months positive chart setup for the $10.45M company. It was reported on Oct, 11 by We have $10.67 PT which if reached, will make NASDAQ:BSPM worth $13.38 million more.

According to Zacks Investment Research, “BioStar Pharmaceuticals, Inc., through its wholly-owned subsidiary, Shaanxi Aoxing Pharmaceutical Co., Ltd., develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Company’s most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, Biostar manufactures two broad-based over-the-counter products, two prescription-based pharmaceuticals and ten nutrients. The Company has adopted international standards and is in the process of applying for three patents. It also operates an herbal medicine planting base which provides it with many of its needed materials at a significantly lower cost than purchasing from third parties, and eliminates most needs for transportation.”

More notable recent Biostar Pharmaceuticals Inc (NASDAQ:BSPM) news were published by: which released: “Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months …” on August 22, 2016, also with their article: “Crazy Stock Move Of The Day: Biostar Pharmaceuticals” published on June 08, 2016, published: “Biostar Pharmaceuticals Signs a Letter of Intent to Acquire Xianyang Yongsheng …” on September 22, 2016. More interesting news about Biostar Pharmaceuticals Inc (NASDAQ:BSPM) were released by: and their article: “Biostar Pharma (BSPM) Announces Launch of ‘Easy Breathing’ Product; Will …” published on October 11, 2016 as well as‘s news article titled: “Biostar Pharmaceuticals Airs Advertisements for its Analgesic (Pain Relief …” with publication date: February 16, 2016.

BSPM Company Profile

Biostar Pharmaceuticals, Inc. (Biostar), incorporated on March 27, 2007, is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, makes and markets pharmaceutical products for various diseases and conditions in the People’s Republic of China (PRC or China). The Firm offers over-the-counter (OTC) products and prescription pharmaceuticals. The Company’s products are derived from medicinal herbs that are either grown at its own facility or purchased from its suppliers. The Company’s products are sold in approximately 30 provinces in the PRC through a network of over 60 distributors and through approximately 230 sales people.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Leave a Comment